Search - tctmd.com

Displaying 721 - 740 of 841

Sort: Relevancy | Date

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

L.A. McKeown

March 30, 2014

News Daily News

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

L.A. McKeown

March 20, 2014

News Daily News

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

L.A. McKeown

March 20, 2014

News Daily News

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

L.A. McKeown

February 26, 2014

News Daily News

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

L.A. McKeown

February 26, 2014

News Daily News

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

L.A. McKeown

February 06, 2014

News Daily News

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

L.A. McKeown

February 06, 2014

News Daily News

Meta分析：达比加群与华法林在房颤、静脉血栓栓塞患者中出血治疗效果比较

L.A. McKeown

January 27, 2014

News Daily News

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

L.A. McKeown

January 27, 2014

News Daily News

Meta Análisis: Buen Perfil Hemorrágico con Dabigatran comparado con Warfarina en el Tratamiento de TEV y FA

L.A. McKeown

January 27, 2014

News Daily News

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

L.A. McKeown

October 15, 2013

News Daily News

Un Estudio Desafía las Directrices sobre Retrasos en Cirugías No Cardíacas tras PCI

L.A. McKeown

October 11, 2013

News Daily News

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

L.A. McKeown

October 11, 2013

News Daily News

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

L.A. McKeown

September 20, 2013

News Daily News

Meta Análisis Confirma Beneficio en Mortalidad CABG sobre PCI en Pacientes Diabéticos

L.A. McKeown

September 20, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

L.A. McKeown

September 20, 2013

Advertisement

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

Mortality Benefit with ACE Inhibitors in Nonobstructive CAD

Beneficio sobre la Mortalidad con Inhibidores de la ECA en la EAC No Obstructiva

NCDR Data Show Post-PCI Transfusion Linked with Poor Outcomes

Los Datos del NCDE Revelan que las Transfusiones post-PCI acarrean Malos Resultados

Las Hemorragias son Frecuentes aunque No Suelen hacerse Públicas en Pacientes SCA a Tratamiento Antiplaquetario

Bleeding Common but Often Unreported in ACS Patients on Antiplatelet Therapy

Meta分析：达比加群与华法林在房颤、静脉血栓栓塞患者中出血治疗效果比较

Meta-analysis: Good Bleeding Profile with Dabigatran vs. Warfarin for A-fib, VTE

Meta Análisis: Buen Perfil Hemorrágico con Dabigatran comparado con Warfarina en el Tratamiento de TEV y FA

Early QOL Advantage of CABG Over PCI for Diabetic Patients Disappears After 2 Years

Un Estudio Desafía las Directrices sobre Retrasos en Cirugías No Cardíacas tras PCI

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

Meta-analysis Confirms Mortality Edge with CABG over PCI in Diabetic Patients

Meta Análisis Confirma Beneficio en Mortalidad CABG sobre PCI en Pacientes Diabéticos

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content